Filing Details
- Accession Number:
- 0001209191-17-066064
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-15 19:30:43
- Reporting Period:
- 2017-12-15
- Accepted Time:
- 2017-12-15 19:30:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1333458 | Joseph Robert Bujarski | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | Svp, Bus Dev & Gen Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-12-15 | 42,038 | $15.19 | 79,797 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-15 | 29,605 | $22.21 | 109,402 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-15 | 21,465 | $27.57 | 130,867 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-15 | 17,596 | $23.41 | 148,463 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-15 | 22,038 | $39.69 | 126,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-15 | 20,000 | $39.69 | 106,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-15 | 20,000 | $39.69 | 86,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-15 | 20,000 | $39.70 | 66,425 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-15 | 28,666 | $40.01 | 37,759 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-15 | 42,038 | $0.00 | 42,038 | $15.19 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-15 | 29,605 | $0.00 | 29,605 | $22.21 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-15 | 21,465 | $0.00 | 21,465 | $27.57 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2017-12-15 | 17,596 | $0.00 | 17,596 | $23.41 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-03-02 | No | 4 | M | Direct | |
| 0 | 2023-02-25 | No | 4 | M | Direct | |
| 7,156 | 2024-02-24 | No | 4 | M | Direct | |
| 17,596 | 2025-02-05 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $39.6897 per share, with a range of $39.21 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $39.6898 per share, with a range of $39.20 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $39.6898 per share, with a range of $39.20 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $39.7049 per share, with a range of $39.50 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $40.0125 per share, with a range of $40.00 to $40.55. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- 21,019 shares vested on 03/02/2014; 10,509 shares vested on 03/02/2015; and 10,510 shares vested on 03/02/2016.
- 14,803 shares vested on 02/25/2015; 7,401 shares vested on 02/25/2016; and 7,401 shares vested on 02/25/2017.
- 14,310 shares vested on 02/24/2016; and 7,155 shares vested on 02/24/2017.
- 17,596 shares vested on 02/05/2017.
Billionaire Hedge Funds
